Better Diabetes Management

Improve Your Health With Continuous Glucose Monitoring

Free Insurance Verification

A CGM Specialist Will Call You!

"*" indicates required fields

How many times do you test your blood sugar?*
Do you use Insulin*
Have you had an office visit with your doctor in the last three to six months?*

Aptiva Medical carries all the leading brands and products you know and trust

The future of Continuous Glucose Monitoring has arrived

Zero Fingersticks
FDA-permitted to allow for zero findersticks.
Share Your Data
Share your glucose data with up to 10 contacts.
Customizable Alerts
Set your range and receive a notification when you’re heading high or low.
Smart Device Compatibility
See glucose data in real time on all your compatible devices.

We make it as easy as

Complete the enrollment form and we’ll call you to explain our service.
We verify your insurance and obtain a prescription from your doctor.
We explain your benefits to you and mail your supplies to your home - FREE of charge!

Libre 14-Day

Libre 2

Dexcom G6

Exceptional service and the most advanced CGM systems

Data from this study was collected with the outside US version of FreeStyle Libre 14 day system. FreeStyle Libre 2 has the same features as FreeStyle Libre 14 day system with optional, real-time glucose alarms. Therefore, the study data is applicable to both products.

Medicare coverage is available for the FreeStyle Libre 2 system if a compatible smartphone is used in conjunction with the FreeStyle Libre 2 reader to review glucose data. Medicare and other third party payor criteria apply.


  • FreeStyle Libre 2 User’s Manual.
  • Haak, Thomas, et al. “Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-treated Type 2 Diabetes: a Multicentre, Open-label Randomised Controlled Trial.” Diabetes Therapy 8, no. 1 (February 2017): 55-73.
  • Al Hayek, Ayman A., Robert A. Asirvatham, and Mohamed A. Al Dawish. “Acceptability of the FreeStyle Libre Flash Glucose Monitoring System: The Experience of Young Patients With Type 1 Diabetes.” Clinical Medical Insights: Endocrinology and Diabetes 13 (March 2020): 1-7.
  • Evans, Mark, et al. “The Impact of Flash Glucose Monitoring on Glycaemic Control as Measured by HbA1c: a Meta-analysis of Clinical Trials and Real-world Observational Studies.” Diabetes Therapy 11, no. 1 (January 2020): 83-95.
  • Kroeger, Jens, Peter Fasching, and Helene Hanaire. “Three European Retrospective Real-World Chart Review Studies to Determine the Effectiveness of Flash Glucose Monitoring on HbA1c in Adults with Type 2 Diabetes.” Diabetes Therapy 11, no. 1 (January 2020): 279-291.
  • Data on File. Abbott Diabetes Care.

Important Information

The information presented here is meant to be strictly for informational and educational purposes. It is not to be considered advice, including medical advice, from Aptiva Medical. None of the information is intended to serve as a substitute for diagnosis from or consultation with a healthcare professional. Always consult your doctor regarding any medical questions that you have, as well as before starting or changing your exercise or diet program and before adjusting any medication.

Fingersticks may be required for diabetes treatment decisions if glucose alerts and CGM readings do not match symptoms or expectations.
ii. Free Home Delivery
iii. Lower your A1c
iv. Most Insurances Accepted

Please call the Physician Relationship team at 1-800-455-5211 to get set up on the DMEscripts platform
Send us an email to